CompoSecure Reports Second Quarter 2023 Financial Results
– Secures Long-Term Contract Renewal for One of Its Largest Customers –
– Reaffirms 2023 Net Sales and Adjusted EBITDA Guidance –
“We continue to demonstrate the performance and consistency of our business as our second quarter results were in-line with our expectations despite continued macroeconomic uncertainties,” said
“We are also pleased to announce a five-year contract extension through
“Throughout our 20 year history, our company has been driven by delivering unmatched value and business impact as well as innovation, while establishing long-term partnerships across the market, and I am proud that we continue to demonstrate that unique value proposition.”
Q2 2023 Financial Highlights (vs. Q2 2022)
Net Sales :Net Sales increased 1% to$98.5 million compared to$97.2 million , with the increase primarily driven by continued domestic growth in the Company’s metal payment card business, which was up 11%. This was partially offset by lower international sales, which is a more variable market due to customer mix and a smaller sales base. International sales remained in-line with the Company’s targeted revenue mix of approximately 20%.- Gross Profit: Gross Profit was
$53.9 million or 54.7% ofNet Sales , compared to$58.9 million or 60.5%. The decrease was primarily due to higher material costs resulting from inflationary pressures and product mix. Gross margin was in-line with the Company’s previously stated mid-50% target. - Net Income/EPS: Net Income was
$32.7 million compared to$60.7 million . The decrease was primarily driven by a$25.4 million change in non-cash mark to market adjustments related to the fair value of warrant liabilities, earnout consideration liability and derivative liability. Net Income per share attributable to class A common stockholders was$0.31 (Basic) and$0.29 (Diluted), compared to$0.56 (Basic) and$0.52 (Diluted) in the year-ago period. - Adjusted Net Income/Adjusted EPS: Adjusted Net Income (a non-GAAP measure) was
$22.9 million compared to$25.3 million in the year-ago period. Adjusted EPS (a non-GAAP measure), which includes both class A and class B shares, was$0.29 (Basic) and$0.25 (Diluted) compared to$0.33 (Basic) and$0.29 (Diluted) in the year-ago period (see reconciliation of non-GAAP measures shown in table below). - Adjusted EBITDA: Adjusted EBITDA (a non-GAAP measure) was
$36.9 million compared to$39.7 million , with the decrease primarily driven by lower gross margin.
Recent Operational Highlights
- Continued metal payment card momentum including Barclays
UK , Citizen’s Bank, Mars (a Turkish based Fintech), and Step Financial. - Signed new Arculus customers for the quarter including Plug Wallet, an online crypto wallet, and Radix DeFi, a decentralized network, among others.
- Arculus was nominated for the Pay Tech Awards, Tech of the Future – Fighting Fraud & Financial Crime award.
- Named a New Jersey Top Workplace by NJ.com for the fourth year in a row.
2023 Financial Outlook
The Company is reaffirming its guidance for full year 2023 results, with net sales expected to be in the range of
Conference Call
The Company will host a conference call and live audio webcast today at
Date:
Time:
Dial-in registration link: here
Live webcast registration link: here
If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.
A live webcast and replay of the conference call will be available on the investor relations section of the Company’s website at https://ir.composecure.com/news-events/events.
About
Founded in 2000,
Forward-Looking Statements
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of management. Although the Company believes that its plans, intentions, and expectations reflected in or suggested by these forward-looking statements are reasonable, the Company cannot assure you that it will achieve or realize these plans, intentions, or expectations. Forward-looking statements are inherently subject to risks, uncertainties, and assumptions. Generally, statements that are not historical facts, including statements concerning the Company’s possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. In some instances, these statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates” or “intends” or the negatives of these terms or variations of them or similar terminology. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements which speak only as of the date hereof. You should understand that the following important factors, among others, could affect the Company’s future results and could cause those results or other outcomes to differ materially from those expressed or implied in the Company’s forward-looking statements: the ability of the Company to grow and manage growth profitably, maintain relationships with customers, compete within its industry and retain its key employees; the possibility that the Company may be adversely impacted by other economic, business, and/or competitive factors; the outcome of any legal proceedings that may be instituted against the Company or others; future exchange and interest rates; and other risks and uncertainties, including those under “Risk Factors” in filings that have been made or will be made with the
Use of Non-GAAP Financial Measures
This press release includes certain non-GAAP financial measures that are not prepared in accordance with accounting principles generally accepted in
Corporate Contact
Head of Communications,
(908) 898-8887
apiniella@composecure.com
Investor Relations Contact
Elevate IR
(720) 330-2829
ir@composecure.com
Condensed Consolidated Balance Sheet Data | |||||||
(in thousands) | |||||||
(unaudited) | |||||||
ASSETS | |||||||
Cash and cash equivalents | $ | 22,614 | $ | 13,642 | |||
Accounts Receivable, net | 36,534 | 37,272 | |||||
Inventories, net | 48,889 | 42,374 | |||||
Prepaid expenses and other current assets | 4,096 | 3,824 | |||||
Property and equipment, net | 24,182 | 22,655 | |||||
Right of use assets operating, net | 8,427 | 8,932 | |||||
Deferred tax asset | 27,968 | 25,569 | |||||
Derivative asset - interest rate swap | 8,329 | 8,651 | |||||
Deposits and other assets | 24 | 24 | |||||
TOTAL ASSETS | $ | 181,063 | $ | 162,943 | |||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
Current portion of long-term debt | $ | 18,750 | $ | 14,372 | |||
Current portion of lease liabilities | 1,892 | 1,846 | |||||
Current portion of tax receivable agreement liability | 1,668 | 2,367 | |||||
Accounts payable | 6,635 | 7,127 | |||||
Accrued expenses | 10,766 | 10,154 | |||||
Commission payable | 5,361 | 3,317 | |||||
Bonus payable | 5,779 | 8,177 | |||||
Long-term debt, net of deferred finance costs | 207,343 | 216,276 | |||||
Convertible notes, net of debt discount | 127,586 | 127,348 | |||||
Derivative liability - convertible notes | 798 | 285 | |||||
Warrant liability | 24,309 | 16,341 | |||||
Earnout consideration liability | 10,869 | 15,090 | |||||
Lease liabilities | 7,257 | 7,766 | |||||
Tax receivable agreement liability | 23,952 | 24,475 | |||||
Total stockholders' (deficit) | (271,902 | ) | (291,998 | ) | |||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | 181,063 | $ | 162,943 | |||
Consolidated Statements of Operations |
|||||||||||||||
(in thousands, except per share amounts) |
|||||||||||||||
(unaudited) |
|||||||||||||||
Three Months Ended |
Six Months Ended |
||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||
Net sales | $ | 98,527 | $ | 97,199 | $ | 193,843 | $ | 181,382 | |||||||
Operating expenses: | |||||||||||||||
Cost of sales | 44,590 | 38,347 | 86,552 | 73,771 | |||||||||||
Selling, General and administrative | 23,588 | 24,433 | 47,532 | 43,209 | |||||||||||
Total operating expenses | 68,178 | 62,780 | 134,084 | 116,980 | |||||||||||
Income from operations | 30,349 | 34,419 | 59,759 | 64,402 | |||||||||||
Total other income (expense), net | 3,331 | 29,041 | (16,605 | ) | 26,509 | ||||||||||
Income before income taxes | 33,680 | 63,460 | 43,154 | 90,911 | |||||||||||
Income tax (expense) benefit | (970 | ) | (2,802 | ) | 293 | (3,345 | ) | ||||||||
Net income | 32,710 | 60,658 | 43,447 | 87,566 | |||||||||||
Net income attributable to non-controlling interests | 26,973 | 52,184 | 35,347 | 75,628 | |||||||||||
Net income attributable to |
$ | 5,737 | $ | 8,474 | $ | 8,100 | $ | 11,938 | |||||||
Net income per share attributable to Class A common stockholders -basic | $ | 0.31 | $ | 0.56 | $ | 0.45 | $ | 0.80 | |||||||
Net income per share attributable to Class A common stockholders - diluted | $ | 0.29 | $ | 0.52 | $ | 0.41 | $ | 0.75 | |||||||
Weighted average shared used to compute net income per share attributable to Class A common stockholders - basic (in thousands) | 18,537 | 15,052 | 18,087 | 14,993 | |||||||||||
Weighted average shared used to compute net income per share attributable to Class A common stockholders - diluted (in thousands) | 35,528 | 32,363 | 35,155 | 32,341 |
Consolidated Statements of Cash Flows | |||||||
(in thousands) | |||||||
(unaudited) | |||||||
Six Months Ended |
|||||||
2023 | 2022 | ||||||
CASH FLOWS FROM OPERATING ACTIVITES: | |||||||
Net income | $ | 43,447 | $ | 87,566 | |||
Adjustments to reconcile net income to net cash provided by operating activities | |||||||
Depreciation | 4,171 | 4,567 | |||||
Stock-based compensation expense | 8,415 | 4,020 | |||||
Amortization of deferred finance costs | 700 | 1,252 | |||||
Change in fair value of earnout consideration liability | (4,221 | ) | (19,041 | ) | |||
Revaluation of warrant liability | 7,968 | (18,041 | ) | ||||
Change in fair value of derivative liability | 513 | 61 | |||||
Deferred tax (benefit) expense | (1,770 | ) | 3,094 | ||||
Changes in assets and liabilities | |||||||
Accounts receivable | 738 | (17,282 | ) | ||||
Inventories | (6,515 | ) | (2,938 | ) | |||
Prepaid expenses and other assets | (272 | ) | (1,144 | ) | |||
Accounts payable | (492 | ) | (201 | ) | |||
Accrued expenses | 612 | 10,262 | |||||
Other liabilities | (313 | ) | (784 | ) | |||
Net cash provided by operating activities | 52,981 | 51,391 | |||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
Acquisition of property and equipment | (5,697 | ) | (3,504 | ) | |||
Net cash used in investing activities | (5,697 | ) | (3,504 | ) | |||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
Proceeds from employee stock purchase plan and exercise of equity awards | 389 | - | |||||
Payments for taxes related to net share settlement of equity awards | (2,483 | ) | - | ||||
Proceeds from line of credit | - | 10,000 | |||||
Payment of Tax receivable agreement liability | (2,193 | ) | - | ||||
Payment of term loan | (5,017 | ) | (16,878 | ) | |||
Distributions | (29,008 | ) | (25,729 | ) | |||
Payment of issuance cost related to business combination | - | (23,833 | ) | ||||
Net cash used in financing activities | (38,312 | ) | (56,440 | ) | |||
Net increase (decrease) in cash and cash equivalents | 8,972 | (8,553 | ) | ||||
Cash and cash equivalents, beginning of period | 13,642 | 21,944 | |||||
Cash and cash equivalents, end of period | $ | 22,614 | $ | 13,391 | |||
Supplementary disclosure of cash flow information | |||||||
Cash paid for interest expense | $ | 13,626 | $ | 9,638 | |||
Supplemental disclosure of non-cash financing activity: | |||||||
Derivative asset - interest rate swap | $ | 8,329 | $ | 5,590 | |||
Non-GAAP Adjusted EBITDA Reconciliation | ||||||||||||||||
(in thousands) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
Net income | $ | 32,710 | $ | 60,658 | $ | 43,447 | $ | 87,566 | ||||||||
Add (less): | ||||||||||||||||
Depreciation | 2,131 | 2,217 | 4,171 | 4,567 | ||||||||||||
Interest expense, net (1) | 5,849 | 5,547 | 12,345 | 10,513 | ||||||||||||
Income tax expense (benefit) | 970 | 2,802 | (293 | ) | 3,345 | |||||||||||
EBITDA | $ | 41,660 | $ | 71,224 | $ | 59,670 | $ | 105,991 | ||||||||
Stock-based compensation | 4,393 | 3,014 | 8,415 | 4,020 | ||||||||||||
Mark to market adjustments (2) | (9,180 | ) | (34,586 | ) | 4,260 | (37,021 | ) | |||||||||
Adjusted EBITDA | $ | 36,873 | $ | 39,652 | $ | 72,345 | $ | 72,990 | ||||||||
(1) Includes amortization of deferred financing cost for the three and six months ended |
||||||||||||||||
(2) Includes the changes in fair value of warrant liability, derivative liabilities and earnout consideration liability for the three and six months ended |
||||||||||||||||
Non-GAAP Adjusted EPS Reconciliation | ||||||||||||||||
(in thousands) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
(in thousands) except per share amounts | ||||||||||||||||
Basic and Diluted: | ||||||||||||||||
Net income | $ | 32,710 | $ | 60,658 | $ | 43,447 | $ | 87,566 | ||||||||
Add (less): provision (benefit) for income taxes | 970 | 2,802 | (293 | ) | 3,345 | |||||||||||
Income before Income taxes | 33,680 | 63,460 | 43,154 | 90,911 | ||||||||||||
Income tax expense (1) | (6,190 | ) | (6,745 | ) | (11,771 | ) | (12,166 | ) | ||||||||
Adjusted net income before adjustments | 27,490 | 56,715 | 31,383 | 78,745 | ||||||||||||
(Less) add: mark-to-market adjustments (2) | (8,985 | ) | (34,399 | ) | 3,747 | (37,082 | ) | |||||||||
Add: stock-based compensation | 4,393 | 3,014 | 8,415 | 4,020 | ||||||||||||
Adjusted net income | $ | 22,898 | $ | 25,330 | $ | 43,545 | $ | 45,683 | ||||||||
Common shares outstanding used in computing earnings per share, basic: | ||||||||||||||||
Class A and Class B common shares (3) | 78,496 | 76,039 | 78,046 | 76,105 | ||||||||||||
Common shares outstanding used in computing earnings per share, diluted: | ||||||||||||||||
Warrants (Public and Private) (4) | 8,094 | 8,094 | 8,094 | 8,094 | ||||||||||||
Equity awards | 3,991 | 4,312 | 4,068 | 4,349 | ||||||||||||
Total Shares outstanding used in computing adjusted earnings per share - diluted | 90,581 | 88,445 | 90,208 | 88,548 | ||||||||||||
Adjusted net income per share- basic | $ | 0.29 | $ | 0.33 | $ | 0.56 | $ | 0.60 | ||||||||
Adjusted net income per share- diluted | $ | 0.25 | $ | 0.29 | $ | 0.48 | $ | 0.52 | ||||||||
1) Calculated using the Company's blended tax rate. | ||||||||||||||||
2) Includes the changes in fair value of warrant liability and earnout consideration liability. | ||||||||||||||||
3) Assumes both Class A shares and Class B shares participate in earnings and are outstanding at the end of the period. | ||||||||||||||||
4) Assumes treasury stock method, valuation at assumed fair market value of |
||||||||||||||||
5) The Company did not include the effect of Exchangeable Notes to its total shares outstanding used in diluted adjusted net income per share. |
Source: CompoSecure, Inc.